🚨TRIGGER WARNING! This post discusses pregnancy loss (PL) at <20 weeks and subsequent management options. Resources: @acog_org and UpToDate. Please review our previous post on Induced abortion (IA). Many of the medical procedures and medications used to perform IA in the U.S. are also crucial for treating and managing PL [ie miscarriage, spontaneous abortion (SA)]. As a result, the legal restrictions to abortion also threaten to limit access to the procedures and medications used for treating PL and prevent medical staff from offering optimal treatment to patients experiencing PL. Bans on medications for IA could occur with the reversal of Roe vs Wade since 20+ states have introduced bills that would restrict or ban medications used for IA. These bans could impact the management of PL, given that two of the drugs (mifeprostone and misoprostol) used for IA are also used to manage PL. This is already occurring in states with abortion bans and restrictions with reports of pharmacists and pharmacies refusing to fill prescriptions for drugs prescribed for pregnancy loss or ectopic pregnancies. In addition, states with restrictive abortion laws are already having providers who are unwilling to do surgical procedures to treat PL. The inability of providers to offer medication management as an option to treat PL could result in more surgical procedures being done, which is problematic for numerous reasons, namely a failure to offer patients proper and appropriate care. Limiting treatment options for those experiencing PL could affect future fertility and even increase the risk of maternal death. #spontaneousabortion #miscarriage #pregnancyloss #earlypregnancyloss #reproductiverights #reproductivejustice #reproductivehealth #roevswade #roevwade #roeyourvote